Research Report for the year 2017

Scientific publications

Journal Articles:
  • Huebner M, Wolkewitz M, Enriquez-Sarano M, Schumacher M: Competing risks need to be considered in survival analysis models for cardiovascular outcomes. J Thorac Cardiov Sur, 2017; 153: 1427-1431. : https://doi.org/10.1016/j.jtcvs.2016.12.039
  • Jansen L, Weberpals J, Kuiper JG, Vissers PAJ, Wolkewitz M, Hoffmeister M, Brenner H: Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study. Int J Cancer, 2017; 141: 62-71. : http://dx.doi.org/10.1002/ijc.30717
  • Paling FP, Troeman DPR, Wolkewitz M, Kalyani R, Prins DR, Weber S, Lammens C, Timbermont L, Goossens H, Malhotra-Kumar S, Sifakis F, Bonten MJM, Kluytmans JAJW: Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU. Bmc Infect Dis, 2017; 17: 643. : https://doi.org/10.1186/s12879-017-2739-4
  • Paling FP, Wolkewitz M, Bode LGM, Klein Klouwenberg PMC, Ong DSY, Depuydt P, de Bus L, Sifakis F, Bonten MJM, Kluytmans JAJW: Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia. Clin Microbiol Infec, 2017; 23: 49.e9-49.e14. : http://dx.doi.org/10.1016/j.cmi.2016.09.022
  • Paling FP, Wolkewitz M, Depuydt P, de Bus L, Sifakis F, Bonten MJM, Kluytmans JAJW: P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia. Antimicrob Resist in, 2017; 6 (online): 38. : http://dx.doi.org/10.1186/s13756-017-0197-9
  • Rylski B, Hahn N, Beyersdorf F, Kondov S, Wolkewitz M, Plonek T, Czerny M, Siepe M: Fate of the dissected aortic arch after ascending replacement in type A aortic dissection†. Eur J Cardio-thorac, 2017; 51: 1127-1134. : https://doi.org/10.1093/ejcts/ezx062
  • Sommer H, Wolkewitz M, Schumacher M, COMBACTE-NET consortium: The time-dependent "cure-death" model investigating two equally important endpoints simultaneously in trials treating high-risk patients with resistant pathogens. Pharm Stat, 2017; 16: 267-279. : https://doi.org/10.1002/pst.1809
  • Timsit J-F, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S, on behalf of the COMBACTE-NET consortium: Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net. Intens Care Med, 2017; 43: 1002-1012. : http://dx.doi.org/10.1007/s00134-017-4802-4
  • von Cube M, Schumacher M, Palomar-Martinez M, Olaechea-Astigarraga P, Alvarez-Lerma F, Wolkewitz M: A case-cohort approach for multi-state models in hospital epidemiology: Stat Med, 2017; 36: 481-495. : http://dx.doi.org/10.1002/sim.7146
  • von Cube M, Schumacher M, Wolkewitz M: Basic parametric analysis for a multi-state model in hospital epidemiology. Bmc Med Res Methodol, 2017; 17: 111. : https://doi.org/10.1186/s12874-017-0379-4
  • Weberpals J, Jansen L, Haefeli WE, Hoffmeister M, Wolkewitz M, Herk-Sukel MPPV, Vissers PAJ, Brenner H: Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study. Sci Rep-uk, 2017; 7 (online): 2911. : https://doi.org/10.1038/s41598-017-02913-8
  • Wolkewitz M, Schumacher M: Survival biases lead to flawed conclusions in observational treatment studies of influenza patients. J Clin Epidemiol, 2017; 84: 121-129. : http://dx.doi.org/10.1016/j.jclinepi.2017.01.008
  • Wolkewitz M, von Cube M, Schumacher M: Multistate Modeling to Analyze Nosocomial Infection Data: An Introduction and Demonstration. Infect Cont Hosp Ep, 2017; 38: 953-959. : https://doi.org/10.1017/ice.2017.107
  • Wolkewitz M, Zortel M, Palomar-Martinez M, Alvarez-Lerma F, Olaechea-Astigarraga P, Schumacher M: Landmark prediction of nosocomial infection risk to disentangle short- and long-stay patients. J Hosp Infect, 2017; 96: 81-84. : https://doi.org/10.1016/j.jhin.2017.01.017
Reviews:
Other publications (type Sonstiges):
  • Heister T, Kaier K, Wolkewitz M: Estimating the burden of nosocomial infections: Time dependency and cost clustering should be taken into account. Am J Infect Control, 2017; 45: 94-95. : http://dx.doi.org/10.1016/j.ajic.2016.07.030
  • Sommer H, Timsit JF, Wolkewitz M, for the COMBACTE-NET Consortium: Bezlotoxumab and Recurrent Clostridium difficile Infection. New Engl J Med, 2017; 376: 1594. : http://dx.doi.org/10.1056/NEJMc1702531
  • Wolkewitz M, Rücker G, Schumacher M: Changes in Rates of Ventilator-Associated Pneumonia. Jama-j Am Med Assoc, 2017; 317: 1580-1581. : http://dx.doi.org/10.1001/jama.2017.2411
  • Wolkewitz M, Schumacher M: Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data. Plos One, 2017; 12: e0175660. : http://dx.doi.org/10.1371/journal.pone.0175660